BATCH-1174 · HPLC 99.06%
Metabolic Regulation
AOD-9604
5 mg lyophilized · single vial
hGH fragment 176-191 studied for lipolytic signaling without the receptor activity of the full growth-hormone chain.
Dispatch schedule
$120.00Research use only
ISO-17025 Batch VerifiedLyophilized Stability
Dosing timeline — 12-Weeks
Per-compound administration schedule across 12 weeks.
WK 1 · 300 mcg / day
WK 2 · 300 mcg / day
WK 3 · 300 mcg / day
WK 4 · 300 mcg / day
WK 5 · 300 mcg / day
WK 6 · 300 mcg / day
WK 7 · 300 mcg / day
WK 8 · 300 mcg / day
WK 9 · 300 mcg / day
WK 10 · 300 mcg / day
WK 11 · 300 mcg / EOD
WK 12 · 300 mcg / EOD
123456789101112
Initiation
WK 1–2
300 mcg / day
Lipolytic pathway priming
Study Arc
WK 3–10
300 mcg / day
Sustained triglyceride turnover
Taper
WK 11–12
300 mcg / EOD
Metabolic baseline return
Kit composition
- 5 mg lyophilized
AOD-9604
Metabolic Regulation
- 1 × 3 mL
Bacteriostatic Water
Reconstitution diluent
- × 30
U-100 Syringes
Precision administration